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Human saphenous vein is a well-established
coronary and peripheral arterial bypass graft con-
duit. However, the human saphenous vein is prone
to vasospasm, which may contribute to graft failure
in aortocoronary and peripheral vascular reconstruc-
tions.1-4 Treatment with papaverine, a phosphodi-
esterase inhibitor that prevents the breakdown of the
cyclic nucleotides, cyclic adenosine monophosphate
(cAMP), and cyclic guanosine monophosphate
(cGMP), has been recommended to prevent vein
graft spasm during arterial reconstructions.1
Smooth muscle migration and proliferation have
been implicated in the pathogenesis of atherosclero-
sis and intimal hyperplasia.5 The activation of the
cGMP pathway has been shown to inhibit vascular
smooth muscle proliferation in vitro and in vivo.6-8
In addition, the activation of the cGMP pathway
inhibits angiotensin II–stimulated migration of
smooth muscle cells.9 Thus, the activation of cyclic
nucleotide-dependent signaling pathways in vascular
smooth muscles may be important in the prevention
of vein graft spasm and vascular remodeling process-
es that lead to both short-term and long-term vein
graft failure. 
Nitric oxide and nitric oxide donors, such as sodi-
um nitroprusside, relax smooth muscle by activating
guanylate cyclase, which leads to increases in intracel-
lular cGMP.10 Other vasodilators, such as prostacyclin
The small heat shock-related protein–20 
is an actin-associated protein
Colleen M. Brophy, MD, Shannon Lamb, BS, and Audrey Graham, BS,
Augusta, Ga
Purpose: The activation of cyclic nucleotide-dependent signaling pathways in vascular
smooth muscle is important for the prevention of vein graft spasm and neointimal
hyperplasia. Cyclic nucleotide-dependent relaxation is associated with an increase in the
phosphorylation of a small heat shock-related protein (HSP20). In this investigation, we
examined the mechanisms by which HSP20 may modulate relaxation.
Methods: The relaxation responses of the bovine carotid artery smooth muscles were
determined in a muscle bath. HSP20 phosphorylation was quantitated with isoelectric-
focusing immunoblots. The association with actin was determined with coimmunopre-
cipitation and cosedimentation. Molecular sieving columns were used to examine the
macromolecular associations of HSP20.
Results: The activation of cyclic nucleotide signaling pathways leads to the complete
relaxation of carotid smooth muscle. This relaxation response is associated with an
increase in the phosphorylation of HSP20. Actin coimmunoprecipitated with HSP20,
and the association of actin with recombinant HSP20 in vitro was phosphorylation-state
dependent. Finally, HSP20 exists in large (>100 kDa) aggregates, which dissociate with
the activation of cyclic nucleotide signaling pathways.
Conclusion: These data support a role of HSP20 phosphorylation in mediating smooth
muscle relaxation, possibly via a direct interaction of large aggregates of HSP20 with the
contractile elements. (J Vasc Surg 1999;29:326-33.)
From the Departments of Surgery, Medicine (Institute for
Molecular Medicine and Genetics), and Cell Biology, Medical
College of Georgia, and the Augusta Veterans Affairs Medical
Center.
This work was supported by an AHA Clinician Scientist Award, a
VA Merit Review Award, and NIH RO1 HL58027-01. Audrey
Graham was a recipient of an SVS/ISCVS student fellowship.
Presented at the Joint Annual Meeting of The Society for Vascular
Surgery and the International Society for Cardiovascular
Surgery, North American Chapter, San Diego, Calif, June
7–10, 1998.
Reprint requests: Colleen M. Brophy, MD, Institute for
Molecular Medicine and Genetics, Medical College of Georgia,
1120 15th St, Augusta, GA 30912.
Copyright © 1999 by The Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/1/94789
and isoproterenol, interact with cell surface receptors,
which leads to the activation of adenylate cyclase with
an increase in cAMP.11 Increases in cGMP and cAMP
lead to the activation of cGMP-dependent protein
kinase (PKG) and cAMP-dependent protein kinase
(PKA), respectively.10,11 We recently have demon-
strated that the activation of either the cAMP/PKA
or the cGMP/PKG pathway leads to a final common
event—an increase in the phosphorylation of a small
heat shock protein (HSP20).12
Together, these findings suggest that the activa-
tion of the cGMP/PKG pathway, which leads to
increases in the phosphorylation of HSP20, may
prevent pathologic functional (vasospasm) and
structural (atherosclerosis/intimal hyperplasia) nar-
rowing of blood vessels. Thus, the elucidation of the
mechanisms by which HSP20 modulates smooth
muscle cell physiology can lead to significant
advances in our understanding of vascular smooth
muscle biology and can target therapeutic approach-
es to pathologic alterations that occur in diseases,
such as vasospasm and intimal hyperplasia.
METHODS
Materials. Electrophoresis reagents and the DC
protein assay kit were from Biorad (Hercules, Calif).
The rabbit anti-HSP20 antibodies from Kato et al13
and the anti–smooth muscle a -actin antibodies (A-
2547) were from Sigma Chemical Corp (St Louis,
Mo). The catalytic subunit of cAMP-dependent
PKA was from Promega (Madison, Wis). The
forskolin, the N-2-hydroxyethylpiperazine-N’-2-
ethane-sulfonic acid, the ethylenediaminetetra-acetic
acid (EDTA), the ethylene glycol-bis(b -aminoethyl
ether)-N,N,N’,N’-tetra-acetic acid, and the (3-([3-
cholamidopropyl]dimethylammonio)-1-propanesul-
fonate (CHAPS) were from Sigma Chemical Corp.
All the other reagents were of analytic grade.
Contractile physiology. Bovine calf carotid arter-
ies were harvested at a local abattoir and dissected free
of adventitial tissue. The arteries were opened longitu-
dinally, and the endothelium was denuded by rubbing
the intima with a cotton-tipped applicator. Transverse
sections of 1 mm were cut and mounted in a tissue
bath with silk suture. One end was anchored to a fixed
glass pipette, and the other to a force transducer (Grass
Instrument Corp, Quincy, Mass). Tension was record-
ed on a strip-chart recorder (Gould Instrument Corp,
Norcross, Ga). The strips were equilibrated for 60
minutes at 37°C in water jacketed chambers that con-
tained Krebs-bicarbonate buffer (120 mmol/L NaCl,
4.7 mmol/L KCl, 1.0 mmol/L MgSO4, 1.0 mmol/L
NaH2PO4, 10 mmol/L glucose, 1.5 mmol/L CaCl2,
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and 25 mmol/L Na2HCO3). The strips were gassed
with 95% O2/5% CO2 and maintained at pH 7.4. The
maximal contractile length was adjusted with repeated
additions of 110 mmol/L KCl, with equimolar
replacement of NaCl. All the data were reported as
percentages of the maximal response to 110 mmol/L
KCl. The agonists and inhibitors were added directly
to the muscle bath.
Isoelectric-focusing immunoblots. Protein (30
m g) was loaded onto a 12 · 15–cm slab of isofocusing
gels that consisted of 4% acrylamide, 0.1% piperazine
diacrylamide, 9 mol/L urea, 5% ampholine (5 parts
6-8, 3 parts 5-7, and 2 parts 3-10), and 2% CHAPS.
The cathode buffer consisted of 20 mmol/L sodium
hydroxide, and the anode buffer of 10 mmol/L phos-
phoric acid. The proteins were focused for 10,000
V/h. The gels were equilibrated for 30 minutes in 10
mmol/L Tris pH 6.8, 3% sodium dodecylsulfate
(SDS), 19% ethanol, and 4% 2-mercaptoethanol. The
gels then were transferred to Immobilon (Millipore
Corp, Bedford, Mass) 100 mAmp for 12 hours. The
blots were fixed with 20% methanol, dried, blocked
with TBS (10 mmol/L Tris, 150 mmol/L NaCl,
0.5% Tween-20, pH 7.4) and 5% milk for 1 hour,
washed three times with TBS, and then probed with
anti-HSP20 antibodies (1:5000 dilution in TBS, 5%
milk) for 1 hour. The blots were washed six times with
TBS and 0.5% Tween-20 and then were probed with
Supersignal Chemiluminescent Substrate (Pierce,
Rockford, Ill) and exposed to film.
Immunoprecipitation. Strips of bovine carotid
artery smooth muscle were homogenized in TBS (0.5
g of tissue per mL of buffer), and then the samples
were centrifuged at 10,000g for 15 minutes. The sol-
uble proteins then were diluted 10-fold with TBS. The
anti-HSP20 antiserum was added to the supernatants
(1:50 dilution). The samples were shaken gently for 14
hours at 4°C. Protein A-sepharose beads (1/10 vol-
ume) were added, and the samples were incubated for
an additional 3 hours at 4°C. The beads were washed
six times with TBS and 0.5% Tween-20. A final wash
of 10 mmol/L Tris pH 7.4 then was done. The pro-
teins were separated on 10% SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) gels, transferred to
Immobilon, and probed as described previously for
isoelectric-focusing immunoblots. The smooth muscle
a -actin was used at a dilution of 1:1000.
Cloning and expression of HSP20. The rat
complementary DNA for HSP20 (from Dr Kato14)
was amplified with phosphocreatinine (PCR) with
sense (GAA TTC ATA TGG AGA TCC GGG TGC
CTG TGC) and antisense (CGT ACT CGA GCT
ACT TGG CAG CAG GTG GTG ACT) primers that
were synthesized by Gibco BRL (Grand Island, NY).
The PCR products were ligated into PCR-script SK
(+) cloning vector and transformed into Escherichia
coli (E coli) supercompetent cells according to the
manufacturer’s directions (PCR-Script SK (+) Cloning
Kit, Stratagene, La Jolla, Calif). The transformed E
coli was plated onto agar plates, which contained ampi-
cillin, methicillin, 5-bromo-4-chloro-3-indoyl- b —D-
galactopyranoside, and isopropyl-b —D-thiogalactopy-
ranoside. The appropriate colonies were selected and
placed overnight in an LB-Amp broth at 37°C.
Plasmid minipreps were performed with the Wizard
miniprep DNA purification system (Promega,
Madison, Wis). The isolated DNA then was sequenced
with an ABI Prism automatic DNA sequencer
(Applied Biosystems, Los Angeles, Calif). The plasmid
then was cut with Xho-1, isolated on a 1% agarose gel,
and inserted into a pET-19b plasmid. The plasmid was
transformed into E coli JM109 cells (Promega,
Madison, Wis), and the plasmid preparations were per-
formed as previously mentioned. The plasmids then
were transformed into BL21(DE3)pLysS cells, which
were inoculated onto agar plates. The colonies then
were inoculated into LB broth, which contained 
carbenicillin and chloramphenicol, and grown for
approximately 2.5 hours at 37°C until the optical den-
sity was 600Au. Isopropyl- b —D-thiogalactopyra-
noside (1 mmol/L) was added for 30”, followed by
rifampicin for 90”. The bacteria were harvested by
means of centrifugation at 2500g for 10 minutes, and
the HSP20 was affinity purified with an HIS-bind
resin column (Novagen, Madison, Wis). Briefly, the
pellets were sonicated in 1· binding buffer, and the
suspension then was centrifuged at 20,000g for 15
minutes. The pellet was resuspended in 5 mL binding
buffer/6 mol/L urea, sonicated, and incubated on ice
for 1 hour. The suspension was centrifuged at 39,000g
for 20 minutes, and the supernatant was filtered
through a 45-m m filter. The supernatant was applied to
the HIS-bind resin column and eluted with the man-
ufacturer’s buffer. Proteins from the fractions were
separated on SDS-PAGE gels, and the fractions that
contained a single band at 20 kDa underwent dialysis
against decreasing concentrations of urea (6 mol/L
urea/1% triton to 0 mol/L urea/1% triton) in PBS.
Finally, the HSP20 underwent dialysis against
PBS/1% CHAPS.
In vitro phosphorylation of recombinant
HSP20. Recombinant HSP20 (50 m mol/L) was
phosphorylated in a reaction mixture, which con-
tained 500 m mol/L adenosine triphosphate, 1
mmol/L MgCl2, and 300 nmol/L of the catalytic
subunit of cAMP-dependent PKA, in PBS for 30 min-
utes at room temperature. The reaction was stopped
with the addition of 100 m mol/L of the cAMP-
dependent PKA inhibitor. Nonphosphorylated
HSP20 was treated with the same reaction mixture
without the cAMP-dependent PKA.
Actin cosedimentation assay. Recombinant
HSP20 was phosphorylated in vitro with the catalyt-
ic subunit of PKA, and the reactions were stopped
with the addition of the peptide inhibitor of PKA.
Phosphorylated and nonphosphorylated HSP20 (10
m mol/L) were added to a reaction mixture, which
contained 10 m mol/L actin, 20 mmol/L Tris-HCL,
pH 7.5, 0.1 mol/L KCl, 2 mmol/L MgCl2, 1
mmol/L adenosine triphosphate, 1 mmol/L dithio-
threitol, and 0.1 mmol/L CaCl2 (buffer A), and incu-
bated for 60 minutes at 20°C. The mixture (100 m L)
then was centrifuged at 100,000g at 4°C with an
airfuge (Beckman, Fullerton, Calif). An SDS sample
buffer (100 m L) was added to the supernatant. The
pellet was resuspended in 100 m L of buffer A and 100
m L of SDS sample buffer. The samples were boiled for
5 minutes and separated on SDS-PAGE (10%) gels.
This protocol separated the filamentous actin, which
was recovered in the pellet, from the globular actin,
which was recovered in the supernatant.
Molecular sieving columns. Strips of bovine
carotid artery smooth muscle were equilibrated in
bicarbonate buffer and treated with buffer alone
(control) or with forskolin (10 m mol/L for 10 min-
utes). The strips were homogenized (0.5 g tis-
sue/1 mL buffer) in 50 mmol/L Tris, 5 mmol/L
EDTA, and pH 7.0 (Tris buffer) with a polytron
homogenizer (Brinkman Instruments, Westbury,
NY). The samples were centrifuged at 10,000g. A
total of 500 m L of the supernatant was applied to a
Centricon-100 tube (Amicon, Beverly, Mass) and
centrifuged at 1000g until the upper volume was less
than 100 m L. Both the upper and lower solutions
were reconstituted to a total volume of 500 m L with
Tris buffer. The samples were mixed 1:1 with the
sample buffer (10 mmol/L ethyleneglycol-bis( b -
aminoethylether)-N,N,N’,N’-tetra-acetic acid, 2
mmol/L EDTA, 10 mmol/L b -mercaptoethanol,
1% glycerol, and 4% SDS in 60 mmol/L Tris, pH
7.0) and separated on 15% SDS-PAGE mini gels.
The proteins were transferred to Immobilon and
probed with anti-HSP20 antibodies followed by
enhanced chemiluminescence reagent.
Statistical analysis. The contractile responses
were normalized to an initial high KCl contraction, 
and the results are reported as a percentage of the KCl
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contraction. The isoelectric-focusing immunoblots
were quantitated with a PhosphorImager with
ImageQuant software (Molecular Dynamics, Sunny-
vale, Calif). The molecular sieving immunoblots were
quantitated with a Shimadzu CS-9000 Diamond
Scanner (Shimadzu Corp, Japan). Statistical analysis
was performed with analysis of variance and Jandel
Scientific Software (San Rafael, Calif). The results are
presented as the mean ± the standard error of the
mean.
RESULTS
Activation of the cAMP/PKA pathway com-
pletely relaxes carotid artery smooth muscle.
Strips of bovine carotid arteries, devoid of endothe-
lium, were precontracted with serotonin (10
m mol/L). Serotonin-induced contractions were
162.2% ± 9.3% greater in magnitude than the initial
high extracellular KCl (110 mmol/L) contraction
(Fig 1). The addition of the adenylate cyclase activa-
tor, forskolin (10 m mol/L) relaxed the muscles to a
level below the baseline (-11.4% ± 3.1% KCl; Fig 1). 
Activation of the cAMP/PKA pathway leads to
an increase in the phosphorylation of HSP20. In
previous studies, we have demonstrated that HSP20
shifts from a basic isoelectric-focusing point to two
more acidic isoforms with phosphorylation.12 With
this property, we developed a technique to quantitate
HSP20 phosphorylation. The phosphorylated and
nonphosphorylated isoforms of HSP20 were separat-
ed with isoelectric-focusing slab gels. The proteins
then were transferred to Immobilon and probed with
affinity purified antibodies that recognize both the
phosphorylated and the nonphosphorylated isoforms
of HSP20.13 Treatment with forskolin (10 m mol/L)
led to a significant increase in the most acidic isoform
of HSP20 (25.5% ± 4.4% compared with the control
values of 6.6% ± 1.6%; P < .05; n = 4; Fig 2).
Actin coimmunoprecipitates with HSP20. To
determine whether HSP20 was associated with the
cytoskeletal or the contractile elements of the smooth
muscle, HSP20 was immunoprecipitated from the
homogenates of the carotid artery smooth muscle.
The immunoprecipitated proteins were separated on
SDS-PAGE gels, transferred to Immobilon, and
Fig 1. Physiologic contractile responses of bovine carotid
artery smooth muscle. Strips of bovine carotid artery
smooth muscle were equilibrated in muscle bath, and,
after initial high KCl contraction (110 mmol/L), strips
were treated with serotonin (10 m mol/L) followed by
forskolin (10 m mol/L). Top panel is representative tracing
in which magnitude of contraction is indicated on y axis
and time on x axis. In lower panel, tension was normalized
to initial high KCl contraction. Forskolin led to a signifi-
cant decrease in the contractile response (n = 10).
S, Serotonin; F, forskolin.
*P < .05, with analysis of variance.
Fig 2. HSP20 phosphorylation. Strips of bovine carotid
artery smooth muscle were equilibrated in physiologic
bicarbonate solution and then treated with forskolin (10
m mol/L). Proteins were separated on isoelectric-focusing
slab gels, transferred to Immobilon, and probed with anti-
HSP20 antibodies. Representative immunoblot is on left
panel, with most acidic isoform, phosphorylated HSP20,
identified with arrow. Quantitative analysis showed that
treatment with forskolin led to significant increase in most
acidic isoform of HSP20 (n = 4, right panel).
C, Control; F, forskolin.
*P < .05, with analysis of variance.
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probed with anti-actin antibodies. Anti-HSP20 anti-
bodies immunoprecipitated HSP20 (data not shown)
and actin (Fig 3).
Phosphorylated HSP20 associates with glob-
ular actin, and nonphosphorylated HSP20 with
filamentous actin. To determine whether the asso-
ciation of HSP20 with actin was phosphorylation
state specific, recombinant HSP20 was expressed in
bacteria and phosphorylated in vitro with the cat-
alytic subunit of PKA. The binding of phosphorylat-
ed and nonphosphorylated HSP20 to smooth mus-
cle actin was evaluated by means of a cosedimenta-
tion assay.15 Filamentous actin (pellet) was separated
from globular actin (supernatant) with high-speed
centrifugation. Phosphorylated HSP20 associated
with globular actin (Fig 4), which suggests that the
phosphorylation of HSP20 may lead to the dissoci-
ation of the molecule from cytoskeletal elements.
HSP20 dissociates from a macromolecular
aggregate with forskolin treatment. Other small
HSPs have been shown to exist in cultured cells in
large macromolecular aggregates, which dissociate
with various stimuli.16 To determine whether
HSP20 exists in large aggregates in intact vascular
smooth muscle and whether these aggregates disso-
ciate with activation of cyclic nucleotide-dependent
signaling pathways, homogenates of carotid arteries
were separated on Centricon-100 (Fisher Scientific,
Norcross, Ga) columns. Most of the immunoreac-
tive HSP20 was in large aggregates in unstimulated
carotid arteries (82.3% ± 3.5% > 100 kDa).
Stimulation with forskolin (10 m mol/L) led to a dis-
sociation of these aggregates (55.0% ± 2.5% > 100
kDa; Fig 5).
DISCUSSION
Although it is clear that the activation of either
the cAMP/PKA or the cGMP/PKG pathway leads
to vasorelaxation,10,11 less is known about the down-
stream events that result in the actual dissociation of
the contractile elements. Because increases in intra-
cellular Ca2+ and myosin light chain phosphorylation
have been implicated in initiating a contractile
response, many investigators have proposed that the
activation of cyclic nucleotide dependent signaling
pathways leads to decreases in intracellular Ca2+ or in
myosin light chain phosphorylation. The phosphory-
lation of myosin light chain kinase by PKA decreases
its sensitivity to activation by Ca2+-calmodulin, which
leads to a decrease in the phosphorylation of the
myosin light chains.17 PKA or PKG activation leads
to changes in the activities of one or more Ca2+ chan-
nels or Ca2+ pumps, which thereby reduces the intra-
cellular Ca2+ concentrations.18,19 However, we and
others have shown that there is no simple correlation
between the extent of myosin light chain phosphory-
lation or the intracellular Ca2+ concentrations and
the state of contraction or relaxation of vascular
smooth muscles.20-25 These data suggest that mech-
anisms other than decreases in myosin light chain
phosphorylation or intracellular Ca2+ concentrations
alone cannot account for vasorelaxation.
A major phosphorylation event that occurs with
cyclic nucleotide-dependent vasorelaxation is an
increase in the phosphorylation of two 20 kDa pro-
teins.20,26,27 We recently identified these 20 kDa
phosphoproteins as different phosphorylated forms
of a small HSP, HSP20.12 In addition, HSP20 can
be phosphorylated in vitro by both PKA and PKG.12
Finally, HSP20 is not phosphorylated in a muscle
that is refractory to cyclic nucleotide-dependent
vasorelaxation—human umbilical artery smooth
muscle.28 Thus, HSP20 appears to be an important
downstream regulator of vasorelaxation that is com-
mon to both the PKA and the PKG pathways.
Activation of the cAMP/PKA pathway with
forskolin leads to the complete relaxation of bovine
Fig 3. Actin coimmunoprecipitates with HSP20. Strips of
bovine carotid arteries were homogenized and 10,000g
supernatants were immunoprecipitated with anti-HSP20
antibodies. Proteins were separated on SDS-PAGE gels and
probed with anti-actin antibodies. The relative mobility of
molecular weight markers is indicated on left of panel.
WC, Preimmunoprecipitation fractions; IP, immunoprecip-
itated proteins; S, supernatant after immunoprecipitation;
–AB, immunoprecipitation without the HSP20 antibodies.
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Fig 5. Molecular sieving of HSP20. Strips of bovine carotid arteries were homogenized, and
100,000g supernatants were separated on Centricon-100 columns. Immunoblots of proteins in
the >100 kDa (upper) fraction and the <100 kDa (lower) fraction were probed with anti-HSP20
antibodies (upper panels). Percentage of immunoreactive HSP20 in the >100 kDa fraction was
determined with densitometry (bottom panel). HSP20 existed in large macromolecular aggre-
gates in unstimulated arteries, which dissociated with forskolin (10 m mol/L) treatment (n = 3).
*P < .05, with analysis of variance.
U, Upper; L, lower; C, unstimulated arteries; F, forskolin.
Fig 4. Actin/HSP20 cosedimentation assay. Actin and recombinant HSP20 that were phos-
phorylated or nonphosphorylated were equilibrated in reaction mixture. The mixture was then
centrifuged at 100,000g, and supernatant and pellet fractions were separated on SDS-PAGE
gels and stained with coomassie (top panels). In a separate experiment, proteins were trans-
ferred to Immobilon and probed with anti-HSP20 antibodies (bottom panel). Relative mobili-
ty of molecular weight markers is indicated on the left of the panel. Bands with relative mobil-
ity of actin (47 kDa) and HSP20 (20 kDa) are indicated on right.
HSP20-P, Phosphorylated HSP20; HSP20-NP, Nonphosphorylated HSP20.
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carotid artery smooth muscle (Fig 1). This relax-
ation is associated with an increase in the more
acidic, phosphorylated isoform of HSP20 (Fig 2).
Although the precise functions of the HSPs are not
known, many HSPs act as “molecular chaperones”
that assist in the assembly, the disassembly, the stabi-
lization, and the internal transport of intracellular
proteins. The association of HSP20 with actin, and
in particular the association of phosphorylated
HSP20 with nonfilamentous actin (Figs 3 and 4),
suggests that HSP20 may be modulating vasorelax-
ation by a direct association with cytoskeletal or con-
tractile elements, such as actin. Finally, the macro-
molecular aggregates of HSP20 dissociate with
forskolin stimulation. This suggests that the function
of HSP20 in vascular smooth muscle may be related
to the state of aggregation of the protein.
Another small HSP, HSP27, has been implicated
in the regulation of the contraction of rectal sphinc-
ter smooth muscle.29 HSP27 is phosphorylated by a
signaling cascade that involves the tyrosine phos-
phorylation of p38 mitogen activated protein kinase
and the activation of mitogen-activated protein
kinase-activated protein-2 kinase-2.30,31 The phos-
phorylation of HSP27 is increased during thrombin-
induced vascular smooth muscle contraction.31
HSP27 also has been shown to be important in the
regulation of actin filament dynamics.32,33 HSP20
was first identified as a byproduct of the purification
of HSP27.13 Thus, it is possible that HSP20 modu-
lates vascular tone through an interaction with
HSP27.
Taken together, these data support a role for the
small HSPs in the regulation of smooth muscle
physiology. The small HSPs may modulate contrac-
tile physiology via an interaction with each other or
with specific cytoskeletal or contractile elements,
and these interactions may be modulated with phos-
phorylation of the molecules.
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